Biotech Stock News (ONCY) (HZNP) (DEPO) (EPZM) (CELG)

Oncolytics Biotech (NASDAQ:ONCY) On July 6, 2015 shares of Oncolytics went up approximately 17% after the company reported positive phase 2 results in patients with pancreatic cancer. The study known as REO 017 recruited up to 34 patients to determine if the company’s drug REOLYSIN would be able to improve upon the clinical benefit rate … Read more